Acute myocarditis following administration of BNT162b2 vaccine

Mhd Baraa Habib; Tahseen Hamamyh; Ahmed Elyas; Mohammed Altermanini; Mawahib Elhassan

doi:10.1016/j.idcr.2021.e01197

Acute myocarditis following administration of BNT162b2 vaccine

IDCases. 2021 Jun 16:25:e01197. doi: 10.1016/j.idcr.2021.e01197. eCollection 2021.

Authors

Mhd Baraa Habib¹, Tahseen Hamamyh², Ahmed Elyas², Mohammed Altermanini¹, Mawahib Elhassan²

Affiliations

¹ Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
² Cardiology Department, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

Abstract

The wide use of vaccines was linked with rare but serious complications in adults, causing a global concern. Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 vaccine.

Keywords: BNT162b2; COVID-19; COVID-19, coronavirus disease 2019; Myocarditis; Pfizer-BioNTech; SARS-COV-2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; Vaccine.

Publication types

Case Reports